Lipella Pharmaceuticals Inc. (LIPO)
OTCMKTS · Delayed Price · Currency is USD
0.0004
+0.0001 (33.33%)
Aug 18, 2026, 11:21 AM EST
Lipella Pharmaceuticals Market Cap
Lipella Pharmaceuticals has a market cap or net worth of $1.39 thousand as of August 18, 2026. Its market cap has decreased by -99.95% in one year.
Market Cap
1.39K
Enterprise Value
-1.59M
Revenue
389.78K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since December 20, 2022, Lipella Pharmaceuticals's market cap has decreased from 27.05M to 1.39K, a decrease of -99.99%. That is a compound annual growth rate of -93.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 17, 2026 | 1.39K | -99.83% |
| Dec 31, 2025 | 831.75K | -77.44% |
| Dec 31, 2024 | 3.69M | -37.72% |
| Dec 29, 2023 | 5.92M | -67.07% |
| Dec 30, 2022 | 17.98M | -33.55% |
| Dec 20, 2022 | 27.05M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| DNAPrint Genomics | 1.30K |
| GlobeStar Therapeutics | 1.24K |
| Adhera Therapeutics | 1.16K |
| ContraFect | 1.07K |
| Trevena | 959.00 |
| American Oriental Bioengineering | 949.00 |
| eFFECTOR Therapeutics | 941.00 |
| Pathfinder Cell Therapy | 667.00 |